Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells.

Tyson JJ, Baumann WT, Chen C, Verdugo A, Tavassoly I, Wang Y, Weiner LM, Clarke R.

Nat Rev Cancer. 2011 Jun 16;11(7):523-32. doi: 10.1038/nrc3081. Review.

PMID:
21677677
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Live or let die: oestrogen regulation of survival signalling in endocrine response.

Butt AJ, Sutherland RL, Musgrove EA.

Breast Cancer Res. 2007;9(5):306. Review.

PMID:
17980055
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Genes related to growth regulation, DNA repair and apoptosis in an oestrogen receptor-negative (MDA-231) versus an oestrogen receptor-positive (MCF-7) breast tumour cell line.

Skog S, He Q, Khoshnoud R, Fornander T, Rutqvist LE.

Tumour Biol. 2004 Jan-Apr;25(1-2):41-7.

PMID:
15192311
[PubMed - indexed for MEDLINE]
4.

Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer.

Boulay A, Rudloff J, Ye J, Zumstein-Mecker S, O'Reilly T, Evans DB, Chen S, Lane HA.

Clin Cancer Res. 2005 Jul 15;11(14):5319-28.

PMID:
16033851
[PubMed - indexed for MEDLINE]
Free Article
5.

Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.

Dorssers LC, van Agthoven T, Brinkman A, Veldscholte J, Smid M, Dechering KJ.

Breast Cancer Res. 2005;7(1):R82-92. Epub 2004 Nov 16.

PMID:
15642172
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines.

Fan P, McDaniel RE, Kim HR, Clagett D, Haddad B, Jordan VC.

Eur J Cancer. 2012 Dec;48(18):3488-98. doi: 10.1016/j.ejca.2012.04.020. Epub 2012 Jun 2.

PMID:
22658320
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The aromatase inhibitor letrozole and inhibitors of insulin-like growth factor I receptor synergistically induce apoptosis in in vitro models of estrogen-dependent breast cancer.

Lisztwan J, Pornon A, Chen B, Chen S, Evans DB.

Breast Cancer Res. 2008;10(4):R56. doi: 10.1186/bcr2113. Epub 2008 Jul 8.

PMID:
18611244
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.

Browne BC, Hochgräfe F, Wu J, Millar EK, Barraclough J, Stone A, McCloy RA, Lee CS, Roberts C, Ali NA, Boulghourjian A, Schmich F, Linding R, Farrow L, Gee JM, Nicholson RI, O'Toole SA, Sutherland RL, Musgrove EA, Butt AJ, Daly RJ.

FEBS J. 2013 Nov;280(21):5237-57. doi: 10.1111/febs.12441. Epub 2013 Aug 19.

PMID:
23876235
[PubMed - indexed for MEDLINE]
9.

Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.

Craig Jordan V, Lewis-Wambi J, Kim H, Cunliffe H, Ariazi E, Sharma CG, Shupp HA, Swaby R.

Breast. 2007 Dec;16 Suppl 2:S105-13. Epub 2007 Aug 24. Review.

PMID:
17719781
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.

Kabos P, Finlay-Schultz J, Li C, Kline E, Finlayson C, Wisell J, Manuel CA, Edgerton SM, Harrell JC, Elias A, Sartorius CA.

Breast Cancer Res Treat. 2012 Sep;135(2):415-32. doi: 10.1007/s10549-012-2164-8. Epub 2012 Jul 24.

PMID:
22821401
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E.

Butt AJ, McNeil CM, Musgrove EA, Sutherland RL.

Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S47-59. Review.

PMID:
16113099
[PubMed - indexed for MEDLINE]
Free Article
12.

Estrogen-related cancer microenvironment of breast carcinoma.

Yamaguchi Y, Hayashi S.

Endocr J. 2009;56(1):1-7. Epub 2008 May 23. Review.

PMID:
18497452
[PubMed - indexed for MEDLINE]
Free Article
13.

Estrogen receptor-mediated processes in normal and cancer cells.

Dickson RB, Stancel GM.

J Natl Cancer Inst Monogr. 2000;(27):135-45. Review.

PMID:
10963625
[PubMed - indexed for MEDLINE]
14.

Estrogen and cancer.

Liang J, Shang Y.

Annu Rev Physiol. 2013;75:225-40. doi: 10.1146/annurev-physiol-030212-183708. Epub 2012 Oct 8. Review.

PMID:
23043248
[PubMed - indexed for MEDLINE]
15.

Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer.

Patani N, Martin LA.

Mol Cell Endocrinol. 2014 Jan 25;382(1):683-94. doi: 10.1016/j.mce.2013.09.038. Epub 2013 Oct 9. Review.

PMID:
24121024
[PubMed - indexed for MEDLINE]
16.

Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1.

Lim KT, Cosgrave N, Hill AD, Young LS.

Breast Cancer Res. 2006;8(3):R33. Epub 2006 Jun 28.

PMID:
16805920
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Genes related to estrogen action in reproduction and breast cancer.

Basu A, Rowan BG.

Front Biosci. 2005 Sep 1;10:2346-72. Review.

PMID:
15970500
[PubMed - indexed for MEDLINE]
18.

New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.

Cepa M, Correia-da-Silva G, da Silva EJ, Roleira FM, Borges M, Teixeira NA.

BMC Cell Biol. 2008 Jul 24;9:41. doi: 10.1186/1471-2121-9-41.

PMID:
18652661
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

Clarke R, Shajahan AN, Riggins RB, Cho Y, Crawford A, Xuan J, Wang Y, Zwart A, Nehra R, Liu MC.

J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):8-20.

PMID:
19444933
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Anti-oestrogens but not oestrogen deprivation promote cellular invasion in intercellular adhesion-deficient breast cancer cells.

Borley AC, Hiscox S, Gee J, Smith C, Shaw V, Barrett-Lee P, Nicholson RI.

Breast Cancer Res. 2008;10(6):R103. doi: 10.1186/bcr2206. Epub 2008 Dec 4.

PMID:
19055788
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk